Lachman Consultant Services
Martin Cranmer is a Senior Associate at Lachman Consultant Services, providing expertise in quality functions within the pharmaceutical, medical devices, and associated industries. Previously, worked at Ranbaxy as the Director of Quality for India & Asia Region 1 and Region 2, overseeing quality systems and compliance. Held positions at Boehringer Ingelheim, Bendigo and Adelaide Bank, Aspen Pharma Pty Ltd, Novartis Consumer Health, World Health Organization, Yarra SA, APS/Berk Pharmaceuticals, and Sterling Health Europe in various quality and regulatory roles. Holds a Ph.D. in Chemistry - Analytical, an M.Sc. in Chemistry - Analytical, and a B.Sc. (Hons) in Chemical Sciences from the University of East Anglia.
This person is not in any offices
Lachman Consultant Services
Experience. Excellence. Founded in 1978, Lachman Consultants serves companies in Pharmaceutical, Medical Device/Combination Products, Biologics, and Regulatory Affairs. Each practice offers industry-leading experience and expertise in its area of focus. Lachman Consultants serves emerging-to-enterprise organizations on a worldwide basis, delivering solutions that include FDA-Related Services, Audits & Mock Inspections, Quality Assurance & Controls, Scientific and Technical Assistance, Systems Evaluation, Regulatory Affairs, and Training, which consistently exceed client requirements and expectations. When it comes to compliance and regulatory affairs, Lachman has set the industry standard through senior consultants, efficient engagements, integrated expertise, and loyal clients.